Overview

Examination Of Vitiligo Skin Samples Before and After UVB Treatment

Status:
Terminated
Trial end date:
2005-12-01
Target enrollment:
0
Participant gender:
All
Summary
The keratinocytes of lesional skin of vitiligo compared to normal and perilesional skin will differentially express genes correlating with melanocyte death. Narrow Band UVB should then hopefully reverse the pattern of gene expression back toward normal.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Mimi Cho, MD
Collaborator:
American Skin Association
Criteria
Inclusion Criteria:

Patients should have non-treated symmetrically active vitiligo for 3 months.

Exclusion Criteria:

Less than 18 years old and older that 65, pregnant women, segmental or nonactive vitiligo,
patients treated for vitiligo in past 3 month, patients on topical steroid medications,
topical tacrolimus or elidel, patients receiving ultraviolet therapy including narrow band
UVB, PUVA or tanning beds.